Is social camouflaging associated with anxiety and depression in autistic adults?


Journal

Molecular autism
ISSN: 2040-2392
Titre abrégé: Mol Autism
Pays: England
ID NLM: 101534222

Informations de publication

Date de publication:
16 02 2021
Historique:
received: 04 11 2020
accepted: 03 02 2021
entrez: 17 2 2021
pubmed: 18 2 2021
medline: 25 9 2021
Statut: epublish

Résumé

There is inconsistent evidence for a clear pattern of association between 'camouflaging' (strategies used to mask and/or compensate for autism characteristics during social interactions) and mental health. This study explored the relationship between self-reported camouflaging and generalised anxiety, depression, and social anxiety in a large sample of autistic adults and, for the first time, explored the moderating effect of gender, in an online survey. Overall, camouflaging was associated with greater symptoms of generalised anxiety, depression, and social anxiety, although only to a small extent beyond the contribution of autistic traits and age. Camouflaging more strongly predicted generalised and social anxiety than depression. No interaction between camouflaging and gender was found. These results cannot be generalised to autistic people with intellectual disability, or autistic children and young people. The sample did not include sufficient numbers of non-binary people to run separate analyses; therefore, it is possible that camouflaging impacts mental health differently in this population. The findings suggest that camouflaging is a risk factor for mental health problems in autistic adults without intellectual disability, regardless of gender. We also identified levels of camouflaging at which risk of mental health problems is highest, suggesting clinicians should be particularly aware of mental health problems in those who score at or above these levels.

Sections du résumé

BACKGROUND
There is inconsistent evidence for a clear pattern of association between 'camouflaging' (strategies used to mask and/or compensate for autism characteristics during social interactions) and mental health.
METHODS
This study explored the relationship between self-reported camouflaging and generalised anxiety, depression, and social anxiety in a large sample of autistic adults and, for the first time, explored the moderating effect of gender, in an online survey.
RESULTS
Overall, camouflaging was associated with greater symptoms of generalised anxiety, depression, and social anxiety, although only to a small extent beyond the contribution of autistic traits and age. Camouflaging more strongly predicted generalised and social anxiety than depression. No interaction between camouflaging and gender was found.
LIMITATIONS
These results cannot be generalised to autistic people with intellectual disability, or autistic children and young people. The sample did not include sufficient numbers of non-binary people to run separate analyses; therefore, it is possible that camouflaging impacts mental health differently in this population.
CONCLUSIONS
The findings suggest that camouflaging is a risk factor for mental health problems in autistic adults without intellectual disability, regardless of gender. We also identified levels of camouflaging at which risk of mental health problems is highest, suggesting clinicians should be particularly aware of mental health problems in those who score at or above these levels.

Identifiants

pubmed: 33593423
doi: 10.1186/s13229-021-00421-1
pii: 10.1186/s13229-021-00421-1
pmc: PMC7885456
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

13

Subventions

Organisme : Medical Research Council
ID : RG46450
Pays : United Kingdom
Organisme : Wellcome Trust
ID : RG58828
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom

Références

Mol Autism. 2015 May 13;6:6
pubmed: 26056560
Lancet Psychiatry. 2014 Jul;1(2):142-7
pubmed: 26360578
J Child Psychol Psychiatry. 2016 Mar;57(3):271-92
pubmed: 26782158
J Anxiety Disord. 2002;16(6):661-73
pubmed: 12405524
J Autism Dev Disord. 2019 May;49(5):1899-1911
pubmed: 30627892
J Autism Dev Disord. 2014 May;44(5):993-1007
pubmed: 24342972
J Autism Dev Disord. 2018 Nov;48(11):3761-3772
pubmed: 29948530
Autism Res. 2018 Jan;11(1):133-141
pubmed: 29159906
J Neurodev Disord. 2013 May 02;5(1):11
pubmed: 23639131
Autism. 2020 May;24(4):809-821
pubmed: 32429817
J Autism Dev Disord. 2020 Dec;50(12):4280-4296
pubmed: 32274604
J Autism Dev Disord. 2007 Oct;37(9):1679-90
pubmed: 17146701
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Autism Res. 2019 Oct;12(10):1516-1528
pubmed: 31274233
Autism Adulthood. 2020 Jun 01;2(2):132-143
pubmed: 32851204
Lancet Psychiatry. 2019 Oct;6(10):819-829
pubmed: 31447415
Autism Res. 2019 Oct;12(10):1505-1515
pubmed: 31207183
J Autism Dev Disord. 2019 Jun;49(6):2389-2402
pubmed: 30790191
Autism. 2022 Feb;26(2):406-421
pubmed: 34180249
J Am Acad Child Adolesc Psychiatry. 2008 Aug;47(8):921-9
pubmed: 18645422
Mol Autism. 2013 Nov 12;4(1):44
pubmed: 24220604
J Autism Dev Disord. 2020 Oct;50(10):3638-3648
pubmed: 31820344
Autism. 2017 Aug;21(6):690-702
pubmed: 27899710
Autism. 2021 Feb;25(2):336-348
pubmed: 33143455
J Autism Dev Disord. 2011 Dec;41(12):1646-57
pubmed: 21331821
J Child Psychol Psychiatry. 2019 Jan;60(1):102-110
pubmed: 29582425
Behav Res Ther. 2002 Jun;40(6):701-15
pubmed: 12051488
Autism. 2020 Apr;24(3):539-543
pubmed: 32299242
Mol Autism. 2018 Jul 31;9:42
pubmed: 30083306
Autism. 2015 Oct;19(7):832-41
pubmed: 26014841
J Autism Dev Disord. 2019 Jul;49(7):2901-2912
pubmed: 31004247
Autism. 2015 Oct;19(7):814-23
pubmed: 25911091
Psychol Med. 2020 Jul;50(9):1463-1474
pubmed: 31238998
Autism Res. 2013 Aug;6(4):237-47
pubmed: 23907924
J Abnorm Child Psychol. 2018 Jan;46(1):183-192
pubmed: 28417276
J Autism Dev Disord. 2017 Aug;47(8):2519-2534
pubmed: 28527095
Autism. 2017 Feb;21(2):155-166
pubmed: 27091948
Autism. 2015 Oct;19(7):785-93
pubmed: 26019306
J Autism Dev Disord. 2019 Feb;49(2):542-555
pubmed: 30151782
J Autism Dev Disord. 2019 Mar;49(3):819-833
pubmed: 30361940
J Child Psychol Psychiatry. 2012 Nov;53(11):1157-66
pubmed: 22909395
J Autism Dev Disord. 2020 Jun;50(6):2217-2225
pubmed: 30847710
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
J Am Acad Child Adolesc Psychiatry. 2015 May;54(5):369-76.e3
pubmed: 25901773
J Autism Dev Disord. 2018 Feb;48(2):473-484
pubmed: 29071566
J Autism Dev Disord. 2016 Oct;46(10):3281-94
pubmed: 27457364
J Autism Dev Disord. 2017 Dec;47(12):3679-3681
pubmed: 28988366
Lancet Psychiatry. 2019 Sep;6(9):766-777
pubmed: 31350208
Autism. 2020 Feb;24(2):352-363
pubmed: 31319684
Res Dev Disabil. 2011 Sep-Oct;32(5):1910-7
pubmed: 21515028
J Autism Dev Disord. 2016 Jun;46(6):1916-1930
pubmed: 26861713
Mol Autism. 2013 Jul 31;4(1):24
pubmed: 23915495
Autism. 2019 Jul;23(5):1210-1223
pubmed: 30354191
Autism. 2016 Apr;20(3):276-94
pubmed: 25948598

Auteurs

Laura Hull (L)

Research Department of Clinical, Educational and Health Psychology, University College London, 1-19 Torrington Place, London, WC1E 7HB, UK.

Lily Levy (L)

Research Department of Clinical, Educational and Health Psychology, University College London, 1-19 Torrington Place, London, WC1E 7HB, UK.
Homerton University Hospital NHS Foundation Trust, London, UK.

Meng-Chuan Lai (MC)

Centre for Addiction and Mental Health and The Hospital for Sick Children, Department of Psychiatry, University of Toronto, Toronto, Canada.
Autism Research Centre, Department of Psychiatry, University of Cambridge, Cambridge, UK.
Department of Psychiatry, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan.

K V Petrides (KV)

London Psychometrics Laboratory, University College London, London, UK.

Simon Baron-Cohen (S)

Autism Research Centre, Department of Psychiatry, University of Cambridge, Cambridge, UK.

Carrie Allison (C)

Autism Research Centre, Department of Psychiatry, University of Cambridge, Cambridge, UK.

Paula Smith (P)

Autism Research Centre, Department of Psychiatry, University of Cambridge, Cambridge, UK.

Will Mandy (W)

Research Department of Clinical, Educational and Health Psychology, University College London, 1-19 Torrington Place, London, WC1E 7HB, UK. w.mandy@ucl.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH